Chronic Infection by Oncogenic Viruses
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".
Deadline for manuscript submissions: 15 September 2024 | Viewed by 1168
Special Issue Editor
Special Issue Information
Dear Colleague,
The study of oncogenic viruses has provided many basic insights into cancer, the most important of which is the identification and functional characterization of many oncogenes and tumor suppressor genes. In contrast to acute viruses, chronic viruses establish a persistent lifelong infection of their host. Chronic viral infections can be classified into different categories: Latent infections, characterized by minimal viral production during the initial and late stages. Productive infections, where persistent viral production occurs throughout the entire span, from initial infection to the late stages. Slow infections are marked by a gradual increase in viral production, starting from the incubation period and progressing to the late stages. The distinction among these stages is defined by the regulation of viral propagation and the alteration of viral gene expression patterns.
In this Special Issue, we will focus on the most recent advances in the understanding of the mechanisms of human oncogenic virus replication and pathogenesis. We will also focus on new developments in treatment, antiviral strategies, and vaccine development.
Prof. Dr. Christophe Nicot
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- virus transmission
- virus replication
- virus pathogenesis
- virus latency
- virus–host interactions
- antiviral immune responses
- virus-induced cellular transformation
- antiviral drugs and vaccines
